Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer.
Yokose T, Kabe Y, Matsuda A, Kitago M, Matsuda S, Hirai M, Nakagawa T, Masugi Y, Hishiki T, Nakamura Y, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Honda K, Kashiro A, Morizane C, Nara S, Kikuchi S, Shibahara T, Itonaga M, Ono M, Minegishi N, Koshiba S, Yamamoto M, Kuno A, Handa H, Sakamoto M, Suematsu M, Kitagawa Y. Yokose T, et al. Among authors: morizane c. Cancers (Basel). 2020 Aug 31;12(9):2469. doi: 10.3390/cancers12092469. Cancers (Basel). 2020. PMID: 32878320 Free PMC article.
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.
Takai E, Totoki Y, Nakamura H, Morizane C, Nara S, Hama N, Suzuki M, Furukawa E, Kato M, Hayashi H, Kohno T, Ueno H, Shimada K, Okusaka T, Nakagama H, Shibata T, Yachida S. Takai E, et al. Among authors: morizane c. Sci Rep. 2015 Dec 16;5:18425. doi: 10.1038/srep18425. Sci Rep. 2015. PMID: 26669280 Free PMC article. Clinical Trial.
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
Kashiro A, Kobayashi M, Oh T, Miyamoto M, Atsumi J, Nagashima K, Takeuchi K, Nara S, Hijioka S, Morizane C, Kikuchi S, Kato S, Kato K, Ochiai H, Obata D, Shizume Y, Konishi H, Nomura Y, Matsuyama K, Xie C, Wong C, Huang Y, Jung G, Srivastava S, Kutsumi H, Honda K. Kashiro A, et al. Among authors: morizane c. J Gastroenterol. 2024 Mar;59(3):263-278. doi: 10.1007/s00535-023-02072-w. Epub 2024 Jan 23. J Gastroenterol. 2024. PMID: 38261000 Free PMC article.
[Tumor markers for pancreatic and biliary tract cancer].
Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M. Takezako Y, et al. Among authors: morizane c. Gan To Kagaku Ryoho. 2004 Sep;31(9):1443-6. Gan To Kagaku Ryoho. 2004. PMID: 15446574 Review. Japanese.
ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.
Watanabe T, Ueno H, Watabe Y, Hiraoka N, Morizane C, Itami J, Okusaka T, Miura N, Kakizaki T, Kakuya T, Kamita M, Tsuchida A, Nagakawa Y, Wilber H, Yamada T, Honda K. Watanabe T, et al. Among authors: morizane c. Br J Cancer. 2015 Feb 17;112(4):704-13. doi: 10.1038/bjc.2014.623. Epub 2015 Jan 20. Br J Cancer. 2015. PMID: 25602965 Free PMC article.
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
Kawasaki Y, Hijioka S, Nagashio Y, Maruki Y, Ohba A, Takeshita K, Takasaki T, Agarie D, Hagiwara Y, Hara H, Okamoto K, Yamashige D, Kondo S, Morizane C, Ueno H, Mizui T, Takamoto T, Nara S, Ban D, Esaki M, Tamada K, Hiraoka N, Saito Y, Okusaka T. Kawasaki Y, et al. Among authors: morizane c. J Gastroenterol. 2023 Jul;58(7):693-703. doi: 10.1007/s00535-023-01995-8. Epub 2023 May 8. J Gastroenterol. 2023. PMID: 37154933
209 results